Ask AI
ProCE Banner Activity

Answers to Frequently Asked Questions on the Rapidly Evolving Landscape in the Management of Patients With Advanced Endometrial Cancer

Clinical Thought

Expert commentary with answers to frequently asked questions posed during a live webinar following the 2024 Society of Gynecologic Oncology Annual Meeting, including experts’ thoughts and strategies on integrating new clinical trial data into treatment of advanced dMMR and pMMR endometrial cancer and the potential for new FDA approvals.

Released: June 12, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Financial Disclosures

Primary Author

Ramez N. Eskander, MD

Julie St. John Endowed Chair in Gynecologic Oncology
Professor, Department of Obstetrics, Gynecology and Reproductive Sciences
Clinical Trials Office Medical Director
Fellowship Director, Gynecologic Oncology
UC San Diego Health
Rebecca and John Moores NCI Designated Comprehensive Cancer Center
La Jolla, California

Ramez N. Eskander, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, BeOne, Daiichi Sankyo, Eisai, Genentech, Genmab, Gilead, GSK, Lilly, Merck, MSD, Natera, Pfizer, PMV, Regeneron, Roche, TORL; advisor: Acurion.

Shannon N. Westin, MD, MPH, FASCO

Professor
Medical Director, Gynecologic Oncology Center
Director, Early Drug Development
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Shannon N. Westin, MD, MPH, FASCO: researcher: AstraZeneca, Avenge Bio, Bayer, BioPath, Clovis/Pharma&, Daiichi Sankyo, Genmab, GSK, Jazz, Loxo, Mereo, Novartis, Nuvectis, Pfizer, Roche/Genentech, Verastem, Zentalis; consultant/advisor/speaker: AbbVie, AstraZeneca, Bayer, Caris, Clovis/Pharma&, Corcept, Daiichi Sankyo, Eisai, Faeth, Genmab, Gilead, GSK, Immunocore, ImmunoGen, Incyte, Lilly, Loxo, Merck, Mereo, NGM Bio, Nuvectis, Ottimo, Pfizer, PMV Pharma, Roche/Genentech, Seagen, Verastem, Zentalis, ZielBio.